SE “USIE IZOTOP” strengthens its international cooperation!

Invited by the SE «USIE IZOTOP» management, on November 8, 2024, representatives of the U.S. Embassy in Ukraine 🇺🇸 and the U.S. Department of Energy National Nuclear Security Administration (U.S. DOE/NNSA) paid a working visit to SE “USIE IZOTOP”.

The American delegation, accompanied by the management and technical specialists of the enterprise, visited the facilities of the SE “USIE IZOTOP” Production Complex, where they got acquainted with the main activities of the enterprise.

The participants discussed current cooperation and further plans for the implementation of joint projects between the U.S. DOE’s National Laboratories and SE “USIE IZOTOP” to enhance the level of safety and security of ionizing radiation sources in Ukraine.

As a result of the meeting, the agreements were reached to initiate the cooperation with the Argonne National Laboratory (ANL), which was interested in the experience and technical expertise of the SE “USIE IZOTOP” specialists in the field of managing ionizing radiation sources.

Employees of the international department of SE “USIE IZOTOP” participated in the VII National SME Forum “United for Sustainability and Recovery”

The employees of the International Department of SE “USIE IZOTOP” participated in the VII National SME Forum “United for Resilience and Recovery,” which took place on November 8, 2024. This event brought together nearly 200 representatives of small and medium-sized businesses, government bodies, embassies, international organizations, projects, business associations, business support organizations, expert communities, and business media.

The forum was organized by the Chamber of Commerce and Industry of Ukraine, the Ministry of Economy of Ukraine, and the United Nations Development Programme (UNDP). Participating in the VII National Forum reaffirmed IZOTOP’s commitment to comprehensive growth and adherence to current trends. We explored advanced approaches to strengthening resilience and ensuring progress in the face of contemporary challenges.

We extend our gratitude to the organizers for the opportunity to be a part of this significant event. We remain open to new opportunities for collaboration and continue to move forward for the sustainable development of our country.

IAIA Mission visited SE “USIE IZOTOP”

On November 6, 2024, a working meeting with a team of experts from the International Atomic Energy Agency (IAEA) took place at SE “USIE IZOTOP.” This important visit was part of the second phase of the IAEA “Support and Assistance Mission on the Safety and Security of Radioactive Sources in Ukraine” (ISAMRAD), aimed at providing support and ensuring the safety and security of ionizing radioactive sources (IRS) in Ukraine.

As part of the Mission, which was accompanied by specialists from the State Nuclear Regulatory Inspectorate of Ukraine (SNRIU) and the State Scientific and Technical Center for Nuclear and Radiation Safety (SSTC NRS), a technical visit to the facilities of the enterprise’s production complex, including the radioisotope product storage facility, was carried out. The participants were familiarized with the main areas of activity of SE “USIE IZOTOP”. The IAEA representatives were shown the practical application of equipment and systems already received as part of the international IAEA RANET network to enhance the radiation safety and physical protection system of SE “USIE IZOTOP” facilities.

The meeting covered a wide range of topics. The experts exchanged views on the preliminary results of the Mission’s tasks and conducted a detailed assessment of the progress achieved in improving the quality of safety and security of IRS at the SE “USIE IZOTOP”.

Based on the discussions held, further plans for cooperation were outlined, and additional needs were agreed upon to strengthen the capabilities of SE “USIE IZOTOP” to meet the highest safety standards.

The President of the Kyiv Chamber of Commerce and Industry, Mykola Zasulsky, and Vice-President, Vitaliy Maystrenko, awarded employees of the SE “USIE IZOTOP” with awards.

On the last day of October, SE “USIE IZOTOP” hosted a delegation from the Kyiv Chamber of Commerce and Industry, led by its President, Honored Economist of Ukraine, Mykola Zasulskyi. The visit was marked by warm, friendly discussions between the enterprise’s leadership and Chamber representatives.

The meeting addressed the relevant aspects of cooperation between SE “USIE IZOTOP” and the Kyiv Chamber of Commerce, resulting in an agreement for the Chamber to assist in identifying foreign partners and conducting a quality system audit for the enterprise.

Volodymyr Kalachyk, Director of SE “USIE IZOTOP,” presented plans for the production of radiopharmaceuticals in Ukraine, introducing the Nuclear Medicine Development Concept, which has received endorsement from the Subcommittee on Oncology Prevention and Control of the Verkhovna Rada’s Committee on Public Health, Medical Assistance and Medical Insurance.

Mykola Zasulskyi highlighted that SE “USIE IZOTOP” is a unique strategic enterprise for Ukraine that continues to advance proactively and ambitiously despite the challenging environment.

President of the Kyiv Chamber of Commerce, Mykola Zasulskyi, along with Vice President, Honored Machine Builder of Ukraine, Vitaliy Maistrenko, presented Chamber awards to the enterprise’s employees.

Advanced training at the Walischmiller (HWM) manufacturing plant in Markdorf, Germany.

SE “USIE IZOTOP” personnel continues to participate in trainings and improve their skills
As part of the international technical assistance project supported by the U.S. Department of Energy, technical specialists of SE “USIE IZOTOP” took part in the training on maintenance and repair of A100 manipulators, which took place from 21 to 25 October 2024 at Walischmiller manufacturing factory (HWM) in Markdorf, Germany.

Manipulators of this type are used in the hot cell of the SE “USIE IZOTOP” production complex for the safe radioactive material management, including repackaging, verification and identification of ionizing radiation sources.
The training included theoretical and practical courses on the key aspects of maintenance, diagnostics, replacement of spare parts and repair of manipulator elements and systems.

Completion of this specialized training course directly at the manufacturer site will help the company’s personnel to expertly maintain manipulators, identify and eliminate potential problems in time, and thus avoid long-term repairs.

SE “USIE IZOTOP” continues to pay great attention to the professional development of its employees, as the high qualification and competence of personnel is the key to safe and high-quality work.

Meeting with the management of the Czech representative office of the international company BECKMAN COULTER and their IMMUNOTECH division, which specializes in the production of radioimmunoassay kits for the diagnosis of cancer and many other diseases

During a business trip focused on advancing nuclear medicine and radioimmunoassay (RIA) diagnostics, representatives of SE “USIE IZOTOP” held a meeting with the leadership of the Czech branch of the international company BECKMAN COULTER and its subsidiary, IMMUNOTECH, which specializes in producing RIA diagnostic kits for oncology and many other diseases. The delegation also toured the company’s extensive production facilities. The visit resulted in agreements to strengthen the cooperation efforts.

Radioimmunoassay (RIA) diagnostics stands as one of the most accurate in-vitro laboratory methods, requiring no physical intervention, thus guaranteeing precise results. The RIA diagnostics is distinguished by its high precision, sensitivity, and specificity – significant advantages that underscore its value.

Interesting fact: IMMUNOTECH’s largest customer for the RIA diagnostic kits is South Korea – a country globally recognized for its high standards in healthcare and impressive cancer recovery rates.

It is worth pointing out that SE “USIE IZOTOP” is actively working to ensure that Ukraine benefits from the advanced radiopharmaceuticals, enhancing cancer diagnostics and treatment.